Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.4369 | 1 | 1 |
Mycobacterium ulcerans | NAD-dependent deacetylase | 0.0893 | 0.2 | 0.5 |
Giardia lamblia | NAD-dependent histone deacetylase Sir2 | 0.2822 | 0.6439 | 0.5549 |
Leishmania major | silent information regulator 2, putative | 0.4369 | 1 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.2822 | 0.6439 | 0.5549 |
Brugia malayi | transcriptional regulator, Sir2 family protein | 0.0893 | 0.2 | 0.2 |
Mycobacterium tuberculosis | Transcriptional regulatory protein | 0.0893 | 0.2 | 0.5 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 3 | 0.4369 | 1 | 1 |
Echinococcus multilocularis | chromatin regulatory protein sir2 | 0.4369 | 1 | 1 |
Loa Loa (eye worm) | sirtuin 4 | 0.0893 | 0.2 | 0.2 |
Leishmania major | sir2-family protein-like protein | 0.0893 | 0.2 | 0.1989 |
Plasmodium vivax | hypothetical protein, conserved | 0.0893 | 0.2 | 1 |
Entamoeba histolytica | Sir2 family transcriptional regulator, putative | 0.4369 | 1 | 1 |
Brugia malayi | NAD-dependent deacetylase SIRT1 | 0.2822 | 0.6439 | 0.6439 |
Trypanosoma cruzi | Silent information regulator 2 related protein 3 | 0.0893 | 0.2 | 0.1989 |
Trypanosoma cruzi | Silent information regulator 2 related protein 1 | 0.4369 | 1 | 1 |
Plasmodium falciparum | transcriptional regulatory protein sir2b | 0.0893 | 0.2 | 1 |
Loa Loa (eye worm) | transcriptional regulator | 0.0893 | 0.2 | 0.2 |
Trypanosoma brucei | Silent information regulator 2 related protein 3 | 0.0893 | 0.2 | 0.1989 |
Leishmania major | NAD dependent deacetylase, putative,transcriptional regulator, Sir2 family protein, nicotinic acid mononucleotide 5,6-dimethylbe | 0.0893 | 0.2 | 0.1989 |
Toxoplasma gondii | histone deacetylase SIR2 | 0.0893 | 0.2 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.4369 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.0014 | 0.0014 |
Trypanosoma cruzi | Silent information regulator 2 related protein 1 | 0.4369 | 1 | 1 |
Plasmodium vivax | NAD-dependent deacetylase, putative | 0.0893 | 0.2 | 1 |
Mycobacterium ulcerans | Sir2-like regulatory protein | 0.0893 | 0.2 | 0.5 |
Brugia malayi | transcriptional regulator, Sir2 family protein | 0.0893 | 0.2 | 0.2 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0014 | 0.0014 |
Echinococcus granulosus | chromatin regulatory protein sir2 | 0.4369 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.4369 | 1 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.4369 | 1 | 1 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 1 | 0.2822 | 0.6439 | 0.5549 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 3 | 0.4369 | 1 | 1 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.2822 | 0.6439 | 0.5549 |
Loa Loa (eye worm) | hypothetical protein | 0.1929 | 0.4383 | 0.4383 |
Loa Loa (eye worm) | hypothetical protein | 0.2822 | 0.6439 | 0.6439 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.4369 | 1 | 1 |
Loa Loa (eye worm) | transcriptional regulator | 0.4369 | 1 | 1 |
Trypanosoma brucei | SIR2-like protein 4, putative | 0.0893 | 0.2 | 0.1989 |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.4369 | 1 | 1 |
Toxoplasma gondii | histone deacetylase SIR2-like | 0.0893 | 0.2 | 1 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 1 | 0.2822 | 0.6439 | 0.5549 |
Entamoeba histolytica | Sir2 family transcriptional regulator, putative | 0.4369 | 1 | 1 |
Loa Loa (eye worm) | transcriptional regulator | 0.0893 | 0.2 | 0.2 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.2822 | 0.6439 | 0.5549 |
Plasmodium falciparum | transcriptional regulatory protein sir2a | 0.0893 | 0.2 | 1 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.2822 | 0.6439 | 0.5549 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.2822 | 0.6439 | 0.5549 |
Trypanosoma brucei | Silent information regulator 2 related protein 1 | 0.4369 | 1 | 1 |
Trypanosoma cruzi | Silent information regulator 2 related protein 3 | 0.0893 | 0.2 | 0.1989 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | > 112.219 um | PUBCHEM_BIOASSAY: Luminescence Biochemical Dose Response HTS to Identify Inhibitors of Luciferase. (Class of assay: confirmatory) [Related pubchem assays: 1663 (Primary HTS), 1678 (Summary of Project)] | ChEMBL. | No reference |
Potency (functional) | 6.5733 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.